15. Epstein-Barr Virus and Post-Transplant Lymphoproliferative Disorders

  1. Deepali Kumar MD, MSc, FRCPC and
  2. Atul Humar MD, MSc, FRCPC
  1. Rebecca Madan MD, MSc1 and
  2. Betsy Herold MD2

Published Online: 5 MAY 2011

DOI: 10.1002/9781444397949.ch15

The AST Handbook of Transplant Infections

The AST Handbook of Transplant Infections

How to Cite

Madan, R. and Herold, B. (2011) Epstein-Barr Virus and Post-Transplant Lymphoproliferative Disorders, in The AST Handbook of Transplant Infections (eds D. Kumar and A. Humar), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444397949.ch15

Editor Information

  1. Transplant Infectious Diseases, University of Alberta, Edmonton, Canada

Author Information

  1. 1

    Division of Pediatric Infectious Diseases, Albert Einstein College of Medicine, New York, NY, USA

  2. 2

    Department of Pediatrics (Infectious Diseases), Department of Microbiology & Immunology, Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, New York, NY, USA

Publication History

  1. Published Online: 5 MAY 2011
  2. Published Print: 13 MAY 2011

ISBN Information

Print ISBN: 9780470658277

Online ISBN: 9781444397949

SEARCH

Keywords:

  • Epstein-Barr virus and post-transplant lymphoproliferative disorders;
  • prevention of Epstein-Barr virus (EBV)-related post-transplant lymphoproliferative disorders (PTLDs);
  • document EBV D/R serostatus pre-transplant;
  • high-risk, EBV PCR monitoring post transplant;
  • simultaneously repeat PCR for confirmation - screening for signs and symptoms of PTLD;
  • low-grade viremia and moderate to high grade viremia;
  • pediatric EBV serology - in donors and recipients <18 months;
  • treatment of PTLD;
  • WHO classification of PTLD;
  • PTLD treatment plans, patient-specific and formulated - multidisciplinary team familiar with PTLD management

Summary

This chapter contains sections titled:

  • Prevention of Epstein-Barr virus (EBV)-related Post-transplant Lymphoproliferative Disorders (PTLDs)

  • Pediatric EBV serology in donors and recipients < 18 monthsa

  • Treatment of PTLDa